Cell TypeCholinergic Projection Neurons
[^1]
LocationNucleus Basalis Meynert, Diagonal Band, Septum
[^2]
NeurotransmitterAcetylcholine
[^3]
ProjectionCortex, Hippocampus, Amygdala
Basal forebrain cholinergic neurons (BFCNs) are the primary source of acetylcholine to the cerebral cortex and hippocampus. These neurons play critical roles in attention, learning, memory formation, and cortical plasticity. In Alzheimer's disease (AD), BFCNs undergo early and severe degeneration, contributing to the characteristic cognitive deficits in memory and attention 1.
| Taxonomy |
ID |
Name / Label |
| Cell Ontology (CL) |
CL:0000108 |
cholinergic neuron |
- Morphology: cholinergic neuron (source: Cell Ontology)
- Morphology can be inferred from Cell Ontology classification
| Database |
ID |
Name |
Confidence |
| Cell Ontology |
CL:0000108 |
cholinergic neuron |
Medium |
| Cell Ontology |
CL:0000787 |
memory B cell |
Medium |
| Cell Ontology |
CL:0000813 |
memory T cell |
Medium |
¶ Anatomy and Morphology
BFCNs are organized in distinct nuclei 2:
| Nucleus |
Abbreviation |
Primary Projection |
| Nucleus Basalis Meynert |
NBM |
Cortex (temporal > frontal > parietal) |
| Horizontal Limb of Diagonal Band |
HDB |
Hippocampus, olfactory bulb |
| Vertical Limb of Diagonal Band |
VDB |
Hippocampus |
| Medial Septal Nucleus |
MS |
Hippocampus (theta rhythm) |
- Large, multipolar neurons: 20-50 μm soma diameter
- Extensive dendritic arborization: Receive diverse inputs
- Long, tortuous axons: Extensive cortical innervation
- Cholinergic phenotype: ChAT-positive, ACh-positive
- ChAT (Choline Acetyltransferase): ACh synthesis enzyme
- VAChT (Vesicular ACh Transporter): ACh packaging
- AChE (Acetylcholinesterase): ACh hydrolysis
- p75NTR: Low-affinity NGF receptor
- Muscarinic receptors: M1 (postsynaptic), M2/M4 (presynaptic)
- Nicotinic receptors: nAChRα7, nAChRα4β2 (cortical)
- TrkA/TrkB: Neurotrophin receptors for survival
- cAMP/PKA: Mediates arousal effects
- PI3K/Akt: Neuroprotective signaling
- MAPK/ERK: Gene expression, plasticity
- PLC/PKC: Second messenger signaling
BFCNs regulate cortical processing through 1:
- Attention: Enhance signal-to-noise ratio
- Memory encoding: Facilitate hippocampal-cortical coupling
- Arousal: Maintain wakefulness
- Plasticity: Enable experience-dependent changes
- Theta generation: MS cholinergic neurons drive theta
- Memory consolidation: Coordinate hippocampal-cortical dialog
- Spatial navigation: Enable place cell function
- Gain modulation: Increase neuronal responsiveness
- Network state: Switch between active/inactive states
- Synaptic plasticity: Enable LTP, enhance learning
BFCNs are selectively vulnerable in AD 2:
- Tau pathology: Neurofibrillary tangles in NBM
- Neuron loss: 50-70% loss by early stages
- Atrophy: Reduced NBM volume
- Hypofunction: Impaired ACh release before cell loss
- APP processing: BFCNs express high APP levels
- Aβ accumulation: In cholinergic terminals
- Nicotinic receptor loss: α4β2 and α7 downregulation
Cholinergic deficits correlate with:
- Memory impairment
- Attention deficits
- Reduced cortical plasticity
- Reduced EEG desynchronization
- Acetylcholinesterase inhibitors: Donepezil, Rivastigmine, Galantamine
- Direct agonists: Muscarinic (limited by side effects)
- Nicotinic modulators: α7 agonists in development
- BDNF delivery: Support cholinergic neuron survival
- Anti-tau therapies: Prevent tangles
- Anti-amyloid approaches: Reduce Aβ load
- Stem cell therapy: Cell replacement approaches
-
Gene therapy: AAV-ChAT delivery
-
Optogenetics: Precise circuit manipulation
-
Combination approaches: AChEIs + disease-modifying
-
Nucleus Basalis Meynert
-
Alzheimer's Disease
-
Acetylcholine
-
Cholinergic System
-
Memory Consolidation
-
Tau Pathology Acetylcholinesterase Inhibitors